To use all functions of this page, please activate cookies in your browser.
My watch list
my.chemeurope.com
my.chemeurope.com
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
FesoterodineThe antimuscarinic Fesoterodine is a drug developed by Schwarz Pharma AG to treat Overactive bladder syndrome.[1] It was recommended for approval by the European Medicines Agency in February 2007, but is not yet available for use.[citation needed] Product highlightReferences
|
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Fesoterodine". A list of authors is available in Wikipedia. |
Last viewed
- Analytica Anacon India changing its location - Conference theme announced
- Devgen and Sumitomo announce extension of crop protection collaboration
- New flame-retardant polyamides and polyesters - Huge potential for application in the electrical/ electronics sector and in transport and construction
- BASF and PETRONAS to build polyisobutene production plant - First such plant in South East Asia
- Uhde wins follow-up contract from the LUKOIL Chemical Group for a PVC plant
